Between the two NLR groups we found further statistically significant differences in other vascular endpoints (prior myocardial infarction (47(3.3%) vs. 48(7.0%), p<0.001) and prior stroke (98(6.8%), vs. 73(10.7), p<0.001) and in inflammatory parameters (CRP (median 3 mg/l (1.5–5.5) vs. 5.6 mg/l (2.3–19.1) and fibrinogen (median 344 mg/dl (308–403.5) vs. 412 mg/dl (345.5–507.5); both p<0.001) as well (Table 2). This evidence concerns the gene CRP and myocardial infarction.